131 related articles for article (PubMed ID: 25546209)
1. FDG PET/CT appearance of tumor thrombus of ovarian vessels masquerading as retroperitoneal fibrosis.
Luo Y; Feng R; Li F
Clin Nucl Med; 2015 Jun; 40(6):501-3. PubMed ID: 25546209
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis.
Yilmaz S; Tan YZ; Ozhan M; Halac M; Asa S; Sönmezoglu K
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):338-9. PubMed ID: 23084017
[TBL] [Abstract][Full Text] [Related]
3. ¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma.
Inoue K; Tsubamoto H; Kawata S; Hao H; Ikeda Y; Oku N; Hirota S
J Obstet Gynaecol Res; 2014 Feb; 40(2):576-82. PubMed ID: 24118160
[TBL] [Abstract][Full Text] [Related]
4. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
Kara T; Kara PO; Gedik GK; Sari O
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
[TBL] [Abstract][Full Text] [Related]
5. [The use of positron emission tomography (18F-FDG PET) in diagnosing chronic periaortitis].
Nemec P; Rehák Z; Fabián P; Soucek M
Vnitr Lek; 2008 Nov; 54(11):1093-9. PubMed ID: 19069683
[TBL] [Abstract][Full Text] [Related]
6. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C
Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
[TBL] [Abstract][Full Text] [Related]
7. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases.
Young PM; Peterson JJ; Calamia KT
Ann Nucl Med; 2008 Jan; 22(1):87-92. PubMed ID: 18250993
[TBL] [Abstract][Full Text] [Related]
8. Increased 18F-FDG uptake of widespread endometriosis mimicking ovarian malignancy.
Ge J; Zuo C; Guan Y; Zhang X
Clin Nucl Med; 2015 Feb; 40(2):186-8. PubMed ID: 25546197
[TBL] [Abstract][Full Text] [Related]
9. Secondary retroperitoneal fibrosis due to polyarteritis nodosa evaluated by F-18 FDG PET/CT.
Taniguchi Y; Kumon Y; Kagawa T; Terada Y
Clin Nucl Med; 2011 Nov; 36(11):1044-5. PubMed ID: 21975401
[No Abstract] [Full Text] [Related]
10. (18)F-Fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of idiopathic retroperitoneal fibrosis associated with mediastinal fibrosis.
Washino S; Hirai M; Matsuzaki A; Kobayashi Y
Ann Nucl Med; 2010 Apr; 24(3):225-9. PubMed ID: 20112003
[TBL] [Abstract][Full Text] [Related]
11. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.
Moroni G; Castellani M; Balzani A; Dore R; Bonelli N; Longhi S; Martinelli I; Messa P; Gerundini P
Eur J Nucl Med Mol Imaging; 2012 Oct; 39(10):1635-42. PubMed ID: 22801728
[TBL] [Abstract][Full Text] [Related]
12. [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.
Bertagna F; Treglia G; Leccisotti L; Bosio G; Motta F; Giordano A; Giubbini R
Jpn J Radiol; 2012 Jun; 30(5):415-21. PubMed ID: 22421932
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
[TBL] [Abstract][Full Text] [Related]
14. Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
Sharma P; Kumar R; Singh H; Jeph S; Sharma JB; Jain SK; Sharma DN; Bal C; Malhotra A
Nucl Med Commun; 2012 Feb; 33(2):185-90. PubMed ID: 22107993
[TBL] [Abstract][Full Text] [Related]
15. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus.
Hara T; Truelove J; Tawakol A; Wojtkiewicz GR; Hucker WJ; MacNabb MH; Brownell AL; Jokivarsi K; Kessinger CW; Jaff MR; Henke PK; Weissleder R; Jaffer FA
Circulation; 2014 Sep; 130(13):1044-52. PubMed ID: 25070665
[TBL] [Abstract][Full Text] [Related]
16. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Jansen I; Hendriksz TR; Han SH; Huiskes AW; van Bommel EF
Eur J Intern Med; 2010 Jun; 21(3):216-21. PubMed ID: 20493425
[TBL] [Abstract][Full Text] [Related]
17. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal fibrosis as a cause of positive FDG PET/CT.
Mehta A; Blodgett TM
J Radiol Case Rep; 2011; 5(7):35-41. PubMed ID: 22470805
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT and contrast-enhanced CT in a one-stop diagnostic procedure: a better strategy for management of patients suffering from retroperitoneal fibrosis?
Guignard R; Simukoniene M; Garibotto V; Ratib O
Clin Nucl Med; 2012 May; 37(5):453-9. PubMed ID: 22475894
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review.
Treglia G; Mattoli MV; Bertagna F; Giubbini R; Giordano A
Rheumatol Int; 2013 Mar; 33(3):549-55. PubMed ID: 23124736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
